Interim results from a large multinational extension trial (guardian(™) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2016-09, Vol.22 (5), p.e445-e449
Hauptverfasser:	Lentz, S R, Cerqueira, M, Janic, D, Kempton, C, Matytsina, I, Misgav, M, Oldenburg, J, Ozelo, M, Recht, M, Rosholm, A, Savic, A, Suzuki, T, Tiede, A, Santagostino, E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Child, Preschool Disease Progression Factor VIII - therapeutic use Female Hemophilia A - complications Hemophilia A - drug therapy Hemorrhage - etiology Hemorrhage - prevention & control Humans International Cooperation Male Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!